Skip to main content
. 2022 Feb 9;477(5):1329–1338. doi: 10.1007/s11010-022-04369-5

Fig. 5.

Fig. 5

Exogenous TGF-β treatment increases the expression level of TGF-β in LX-2 cells. LX-2 cells were treated with 10 ng/mL TGF-β for 24 h. Cell lysates were prepared and the protein levels of active IL-1β (a) and TGF-β (b) were analyzed by western blotting. β-actin and GAPDH were used as the internal controls. Representative western blots (upper panel) and densitometric quantification (lower panel) are shown. Data are means ± SEM. **p < 0.01 vs. CON. (n = 3/group)